vs
Side-by-side financial comparison of AbCellera Biologics Inc. (ABCL) and Eos Energy Enterprises, Inc. (EOSE). Click either name above to swap in a different company.
Eos Energy Enterprises, Inc. is the larger business by last-quarter revenue ($58.0M vs $44.9M, roughly 1.3× AbCellera Biologics Inc.). AbCellera Biologics Inc. runs the higher net margin — -19.9% vs -207.7%, a 187.7% gap on every dollar of revenue. On growth, AbCellera Biologics Inc. posted the faster year-over-year revenue change (788.4% vs 699.6%). AbCellera Biologics Inc. produced more free cash flow last quarter ($-44.6M vs $-75.2M).
AbCellera Biologics Inc. is a Vancouver, British Columbia-based biotechnology company that discovers and develops antibody therapeutics. The company is best known for its leading role in the Pandemic Prevention Platform, a project of DARPA's Biological Technologies Office. AbCellera utilizes a proprietary technology platform, which they claim can develop "medical countermeasures within 60 days." Its platform for single-cell screening was initially developed at the University of British Columbia.
Eos Energy Enterprises, Inc. is an energy storage solutions provider that designs, produces and deploys safe long-duration zinc-based battery systems. It serves utility, commercial, industrial and microgrid customers across North America, Europe and Asia, supporting grid stability and renewable energy integration.
ABCL vs EOSE — Head-to-Head
Income Statement — Q4 FY2025 vs Q4 FY2025
| Metric | | |
|---|---|---|
| Revenue | $44.9M | $58.0M |
| Net Profit | $-8.9M | $-120.5M |
| Gross Margin | — | -93.8% |
| Operating Margin | -63.7% | -140.1% |
| Net Margin | -19.9% | -207.7% |
| Revenue YoY | 788.4% | 699.6% |
| Net Profit YoY | 73.9% | 55.1% |
| EPS (diluted) | $-0.03 | $-0.53 |
Green = leading value per metric. Periods may differ when fiscal calendars don't align.
8-Quarter Revenue & Profit Trend
Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.
| Q4 25 | $44.9M | $58.0M | ||
| Q3 25 | $9.0M | $30.5M | ||
| Q2 25 | $17.1M | $15.2M | ||
| Q1 25 | $4.2M | $10.5M | ||
| Q4 24 | $5.0M | $7.3M | ||
| Q3 24 | $6.5M | — | ||
| Q2 24 | $7.3M | — | ||
| Q1 24 | $10.0M | — |
| Q4 25 | $-8.9M | $-120.5M | ||
| Q3 25 | $-57.1M | $-641.4M | ||
| Q2 25 | $-34.7M | $-222.9M | ||
| Q1 25 | $-45.6M | $15.1M | ||
| Q4 24 | — | $-268.1M | ||
| Q3 24 | $-51.1M | — | ||
| Q2 24 | $-36.9M | — | ||
| Q1 24 | $-40.6M | — |
| Q4 25 | — | -93.8% | ||
| Q3 25 | — | -111.2% | ||
| Q2 25 | — | -203.2% | ||
| Q1 25 | — | -234.7% | ||
| Q4 24 | — | -324.0% | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | -63.7% | -140.1% | ||
| Q3 25 | -851.8% | -200.6% | ||
| Q2 25 | -290.2% | -419.1% | ||
| Q1 25 | -1479.6% | -506.2% | ||
| Q4 24 | — | -712.8% | ||
| Q3 24 | -1439.4% | — | ||
| Q2 24 | -1276.2% | — | ||
| Q1 24 | -551.5% | — |
| Q4 25 | -19.9% | -207.7% | ||
| Q3 25 | -637.8% | -2102.1% | ||
| Q2 25 | -203.3% | -1463.2% | ||
| Q1 25 | -1077.2% | 144.7% | ||
| Q4 24 | — | -3696.7% | ||
| Q3 24 | -785.4% | — | ||
| Q2 24 | -504.3% | — | ||
| Q1 24 | -408.0% | — |
| Q4 25 | $-0.03 | $-0.53 | ||
| Q3 25 | $-0.19 | $-4.91 | ||
| Q2 25 | $-0.12 | $-1.05 | ||
| Q1 25 | $-0.15 | $-0.20 | ||
| Q4 24 | — | $-2.30 | ||
| Q3 24 | $-0.17 | — | ||
| Q2 24 | $-0.13 | — | ||
| Q1 24 | $-0.14 | — |
Balance Sheet & Financial Strength
Snapshot of each company's liquidity, leverage and book value from the latest quarter.
| Metric | | |
|---|---|---|
| Cash + ST InvestmentsLiquidity on hand | $128.5M | $568.0M |
| Total DebtLower is stronger | — | $813.3M |
| Stockholders' EquityBook value | $966.9M | $-2.2B |
| Total Assets | $1.4B | $885.2M |
| Debt / EquityLower = less leverage | — | — |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $128.5M | $568.0M | ||
| Q3 25 | $83.2M | $58.7M | ||
| Q2 25 | $92.4M | $120.2M | ||
| Q1 25 | $159.3M | $82.6M | ||
| Q4 24 | $156.3M | $74.3M | ||
| Q3 24 | $126.6M | — | ||
| Q2 24 | $148.3M | — | ||
| Q1 24 | $123.6M | — |
| Q4 25 | — | $813.3M | ||
| Q3 25 | — | $448.5M | ||
| Q2 25 | — | $445.3M | ||
| Q1 25 | — | $325.5M | ||
| Q4 24 | — | $316.9M | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
| Q4 25 | $966.9M | $-2.2B | ||
| Q3 25 | $964.0M | $-2.3B | ||
| Q2 25 | $1.0B | $-1.1B | ||
| Q1 25 | $1.0B | $-942.2M | ||
| Q4 24 | $1.1B | $-1.1B | ||
| Q3 24 | $1.1B | — | ||
| Q2 24 | $1.1B | — | ||
| Q1 24 | $1.1B | — |
| Q4 25 | $1.4B | $885.2M | ||
| Q3 25 | $1.4B | $328.2M | ||
| Q2 25 | $1.4B | $361.0M | ||
| Q1 25 | $1.3B | $263.3M | ||
| Q4 24 | $1.4B | $260.3M | ||
| Q3 24 | $1.4B | — | ||
| Q2 24 | $1.4B | — | ||
| Q1 24 | $1.5B | — |
Cash Flow & Capital Efficiency
How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.
| Metric | | |
|---|---|---|
| Operating Cash FlowLast quarter | $-34.7M | $-50.3M |
| Free Cash FlowOCF − Capex | $-44.6M | $-75.2M |
| FCF MarginFCF / Revenue | -99.4% | -129.7% |
| Capex IntensityCapex / Revenue | 21.9% | 43.1% |
| Cash ConversionOCF / Net Profit | — | — |
| TTM Free Cash FlowTrailing 4 quarters | $-174.1M | $-265.0M |
8-quarter trend — quarters aligned by calendar period.
| Q4 25 | $-34.7M | $-50.3M | ||
| Q3 25 | $-52.6M | $-65.9M | ||
| Q2 25 | $-32.4M | $-66.1M | ||
| Q1 25 | $-11.6M | $-28.9M | ||
| Q4 24 | $-108.6M | $-42.7M | ||
| Q3 24 | $-28.9M | — | ||
| Q2 24 | $-30.0M | — | ||
| Q1 24 | $-41.7M | — |
| Q4 25 | $-44.6M | $-75.2M | ||
| Q3 25 | $-61.5M | $-82.7M | ||
| Q2 25 | $-45.8M | $-73.2M | ||
| Q1 25 | $-22.2M | $-33.8M | ||
| Q4 24 | $-187.0M | $-55.8M | ||
| Q3 24 | $-47.4M | — | ||
| Q2 24 | $-50.1M | — | ||
| Q1 24 | $-65.8M | — |
| Q4 25 | -99.4% | -129.7% | ||
| Q3 25 | -687.0% | -271.1% | ||
| Q2 25 | -267.9% | -480.2% | ||
| Q1 25 | -524.0% | -323.6% | ||
| Q4 24 | -3702.8% | -769.1% | ||
| Q3 24 | -728.4% | — | ||
| Q2 24 | -683.8% | — | ||
| Q1 24 | -661.5% | — |
| Q4 25 | 21.9% | 43.1% | ||
| Q3 25 | 99.7% | 55.2% | ||
| Q2 25 | 78.2% | 46.2% | ||
| Q1 25 | 251.1% | 47.0% | ||
| Q4 24 | 1552.7% | 180.6% | ||
| Q3 24 | 284.6% | — | ||
| Q2 24 | 274.6% | — | ||
| Q1 24 | 242.5% | — |
| Q4 25 | — | — | ||
| Q3 25 | — | — | ||
| Q2 25 | — | — | ||
| Q1 25 | — | -1.91× | ||
| Q4 24 | — | — | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
Financial Flow Comparison
Revenue → gross profit → operating profit → net profit for each company.
